Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 62
Filter
1.
Sr Care Pharm ; 39(7): 238-239, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38937895
4.
Sr Care Pharm ; 39(4): 127-128, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38528339

Subject(s)
Pharmacists , Humans
5.
6.
Sr Care Pharm ; 39(2): 50-51, 2024 Feb 01.
Article in English | MEDLINE | ID: mdl-38263571

Subject(s)
Communication , Family , Humans
7.
Sr Care Pharm ; 39(1): 1-2, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38160241
8.
Sr Care Pharm ; 38(12): 488-489, 2023 Dec 01.
Article in English | MEDLINE | ID: mdl-38041228

ABSTRACT

Professional practice in any complex health care delivery can proceed at a hectic pace. There are often competing demands for the allocation of time and expertise. Senior care pharmacists are among several subsets within the pharmacy profession who shoulder the responsibility to provide care for and to protect older people who can be at grave risk for health problems from a variety of sources, in particular: medication-related problems. This was elegantly elaborated by influential pharmacy practitioners in practice and academia a little more than 30 years ago.


Subject(s)
Community Pharmacy Services , Pharmacies , Pharmacy , Humans , Aged , Pharmacists , Professional Practice
9.
Sr Care Pharm ; 38(11): 450-451, 2023 11 01.
Article in English | MEDLINE | ID: mdl-37885099

Subject(s)
Pharmacists , Humans
10.
Sr Care Pharm ; 38(10): 393-394, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37771060

ABSTRACT

Just as practitioners in the 1980s were blissfully unaware of what the future held, today's new practitioners can only speculate about the future of the profession. To move the profession forward will require singular focus upon the core values of what pharmacists can and should represent in the health care system.


Subject(s)
Delivery of Health Care , Pharmacists , Humans
11.
Sr Care Pharm ; 38(9): 348-349, 2023 09 01.
Article in English | MEDLINE | ID: mdl-37612852
12.
Sr Care Pharm ; 38(8): 307-308, 2023 08 01.
Article in English | MEDLINE | ID: mdl-37496172
16.
Sr Care Pharm ; 38(4): 115-116, 2023 04 01.
Article in English | MEDLINE | ID: mdl-36949565
17.
Sr Care Pharm ; 38(3): 72-73, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36803704
18.
Sr Care Pharm ; 38(1): 1-2, 2023 Jan 01.
Article in English | MEDLINE | ID: mdl-36751923

ABSTRACT

In fact, there is evidence to suggest that a sizable proportion of older people who are at substantially increased risk from the effects of medications acting in the central nervous system are indeed prescribed opioids, antipsychotics, and other drugs that may cause delirium as a side effect. In many instances, this prescription occurs in a dearth of evidence for any worthwhile benefit, and, at the same time, in full knowledge of the fact that the medications may cause harm. Even worse is that, in some cases, the older people who are given these medications are commonly affected by disorders of cognition, unable to communicate their symptoms effectively, and may have a diminished capacity to report side effects associated with the drugs. For health care practitioners who have spent time working in long-term care facilities or hospitals that provide care for older people, this phenomenon is only too well known.


Subject(s)
Antipsychotic Agents , Delirium , Humans , Aged , Antipsychotic Agents/adverse effects , Prescriptions , Analgesics, Opioid/therapeutic use , Hospitals , Delirium/chemically induced , Delirium/drug therapy
19.
Sr Care Pharm ; 38(2): 43-44, 2023 Feb 01.
Article in English | MEDLINE | ID: mdl-36751938

ABSTRACT

In modern times, there has been an enormous explosion of therapeutic options for various conditions, conferring what would, at times, be a bewildering spectrum of choices for prescribers. In some ways, the issue has moved beyond whether a treatment is available or not, beyond the subtleties of choice in terms of efficacy, and even beyond the balance of potential benefit compared with the possibility of treatment-related harm. For many, the primary consideration is simply: access.


Subject(s)
Health Services Accessibility , Pharmaceutical Preparations , Pharmaceutical Preparations/supply & distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...